Combating Ebola: From the Lab to the Last Mile | Johnson & Johnson

Share it with your friends Like

Thanks! Share it with your friends!


Seven years ago, Johnson & Johnson mobilized resources to respond to the deadliest Ebola outbreak ever—and our dedication to fighting the disease hasn’t stopped there.

J&J is providing up to 200,000 courses of our vaccine to a World Health Organization (WHO) early access clinical program to address the recent outbreak in West Africa, and is excited to announce our vaccine regimen has been granted Prequalification status from the WHO.

Learn more about these milestones and how they are marking progress in our decades long commitment to outsmarting pandemics and delivering for communities worldwide:

Subscribe to Johnson & Johnson on YouTube and keep up-to-date with our latest videos:

Connect with Johnson & Johnson on social media:
J&J on Facebook:
J&J News on Twitter:
J&J on LinkedIn:

Find updates and news about Johnson & Johnson:


Write a comment